01 1Bajaj Healthcare
02 1Bakul Group
03 1Bulat Pharmaceutical
04 1Cangzhou Senary Chemical Science-tech Co., Ltd
05 1Jinan Lead Pharmaceutical Technology
06 1Kimia Biosciences
07 1Kores India Limited
CAS Number : 93703-24-3
End Use API :
End Use API : Linagliptin
About the Company : Bajaj Healthcare Ltd. is a company established in 1993, services various Pharmaceuticals, Nutraceutical and Food industries globally with a spirit of scrupulousness. Bajaj Healthcare...
CAS Number : 93703-24-3
End Use API :
End Use API : Linagliptin
About the Company : The Bakul Group of companies headquartered in Mumbai, India are engaged in the development and manufacture of high-quality Active Pharmaceutical Ingredients (APIs), Intermediates, and S...
CAS Number : 93703-24-3
End Use API :
End Use API : Linagliptin
About the Company : Bulat Pharmaceutical is a fast growing pharmaceutical company, founded in the year 2017, Bulat Pharmaceutical is engaged in the manufacturing and sales of high quality APIs and Intermed...
CAS Number : 93703-24-3
End Use API :
End Use API : Linagliptin
About the Company : Founded in 2003, Senary Chem is one of the Key High-Tech Enterprises of National Torch Plan. Senary located in National Cangzhou Lingang Economic and Technological Development Zone,Cang...
CAS Number : CAS-93703-24-3
End Use API :
End Use API : Linagliptin
About the Company : Jinan Lead Pharmaceutical Technology Co., LTD., located in Jinan, Shandong Province, is mainly engaged in R&D, production and sales of pharmaceutical raw materials and intermediates. Th...
CAS Number : 93703-24-3
End Use API :
End Use API : Linagliptin
About the Company : Kimia Biosciences, established in 1993, is focused on manufacturing bulk drugs for various therapeutic segments. With a strong emphasis on excellence and advanced technologies, Kimia ai...
CAS Number : 93703-24-3
End Use API :
End Use API : Linagliptin
About the Company : The division was established in 1981 as a Specialty Chemicals Division with a focus to manufacture specialty chemicals and pharmaceutical intermediates. In April 2006, the division has ...
